Two pills provided greater glucose-lowering efficacy than three with low hypoglycemia risk.
Read More »Supporters of New Classification of Diabetes
In part seven of this special interview with DIC publisher Steve Freed, Dr. Stanley Schwartz discusses the supporters of the new classification of diabetes, such as the role of SGLT-2 inhibitors in improving cardiovascular outcomes, reducing weight, and targeting treatments for the mediating pathways of hyperglycemia.
Read More »A Possible Role for SGLT-2 Inhibitors in Blood Pressure Control
New studies indicate potential class effect in reducing hypertension.
Read More »Dapagliflozin Significantly Improves Blood Pressure
New study shows benefit for patients receiving calcium channel blocker or beta-blocker.
Read More »Where Do SGLT-2 Inhibitors Fit in Diabetes Care?
Various T2 factors create need for multiple treatment options.
Read More »Assessing the Latest Information on SGLT-2 Inhibitors and Ketoacidosis
To maintain the benefits while minimizing risk, consider patient risk factors when prescribing, and monitor for DKA and UTI.
Read More »SGLT-2 Inhibitor Reduces Risk of Cardiovascular Death: Should Current Guidelines be Impacted?
New study generates lively discussion among experts at EASD on how to consider the results in prescribing, exploration of possible mechanism and potential class effect.
Read More »The Present and Future of Insulin Therapy Part 18
In this week's Homerun Slides, the effect of dapagliflozin on endogenous glucose production, plasma insulin and glucagon concentration.
Read More »Experts Conclude that Risk-Benefit Ratio Overwhelmingly Favors Continued Use of SGLT-2
Diabetes experts conclude diabetes treatment should continue with no changes in current recommendations.
Read More »The Present and Future of Insulin Therapy, Part 9
In this week’s Homerun Slides, we look at SGLT2 Inhibition as a novel treatment strategy for type 2 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.